These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35410106)

  • 1. COVID-19 associated pulmonary aspergillosis. A real problem?
    Venturini S; Reffo I; Sagnelli V; Avolio M; Fossati S; Callegari A; DE Rosa R; Pellis T; Nadalin G; Crapis M
    Minerva Anestesiol; 2022 Apr; 88(4):314-315. PubMed ID: 35410106
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a deadly complication.
    Kosmidis C; Hoenigl M
    Thorax; 2023 Dec; 79(1):9-10. PubMed ID: 37940199
    [No Abstract]   [Full Text] [Related]  

  • 3. Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19.
    Benedetti MF; de Abreu MS; Cadena RC; Arias MC; Posse G; Capece P; Nusblat A; Cuestas ML
    J Mycol Med; 2022 May; 32(2):101251. PubMed ID: 35123158
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19-associated Aspergillus Tracheobronchitis.
    Inada T; Kataoka J
    Intern Med; 2023 Aug; 62(16):2441-2442. PubMed ID: 37258156
    [No Abstract]   [Full Text] [Related]  

  • 5. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis.
    de Brabander J; Boers LS; Kullberg RFJ; Duitman JW; Bos LDJ;
    Lancet Respir Med; 2022 Mar; 10(3):e25-e26. PubMed ID: 35122732
    [No Abstract]   [Full Text] [Related]  

  • 6. Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply.
    Gangneux JP; Morcet J; Laviolle B; Dannaoui E; Timsit JF; Ruckly S; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Mar; 10(3):e27. PubMed ID: 35122731
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis].
    Scharf C; Zoller M; Liebchen U
    Anaesthesist; 2021 May; 70(5):432-433. PubMed ID: 33635372
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic pulmonary aspergillosis: help is on the way.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2016 Feb; 4(2):83. PubMed ID: 26868621
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspergillus pericardial empyema successfully treated with percutaneous drainage in a patient with invasive pulmonary aspergillosis.
    Gorospe L; Cobos-Alonso J; Ventura-Díaz S; Mirambeaux-Villalona RM; Cabañero-Sánchez A; Muñoz-Molina GM; Chinea-Rodríguez A
    Ann Hematol; 2022 Dec; 101(12):2793-2794. PubMed ID: 36123453
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation of a diagnostic algorithm for COVID-19-associated pulmonary aspergillosis.
    O'Shea M; Birkhamshaw E; Khalil R; Wickramasinghe N; Hamad M; Crooks N; Winzor G
    J Hosp Infect; 2022 Nov; 129():203-206. PubMed ID: 35940289
    [No Abstract]   [Full Text] [Related]  

  • 11. Call for evidence mapping in accordance with the changing features of invasive pulmonary aspergillosis during the coronavirus disease 2019 pandemic.
    Yoon YK
    Korean J Intern Med; 2022 Jul; 37(4):742-744. PubMed ID: 35811364
    [No Abstract]   [Full Text] [Related]  

  • 12. Invasive aspergillosis in patients with severe COVID-19 pneumonia.
    Helleberg M; Steensen M; Arendrup MC
    Clin Microbiol Infect; 2021 Jan; 27(1):147-148. PubMed ID: 32768493
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19-associated pulmonary aspergillosis: adding insult to injury.
    Bruno G; Fabrizio C; Buccoliero GB
    Lancet Microbe; 2020 Jul; 1(3):e106. PubMed ID: 32835340
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.
    Le Daré B; Boglione-Kerrien C; Reizine F; Gangneux JP; Bacle A
    Crit Care; 2021 Apr; 25(1):152. PubMed ID: 33879175
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosing COVID-19-associated pulmonary aspergillosis.
    Verweij PE; Gangneux JP; Bassetti M; Brüggemann RJM; Cornely OA; Koehler P; Lass-Flörl C; van de Veerdonk FL; Chakrabarti A; Hoenigl M; ; ; ;
    Lancet Microbe; 2020 Jun; 1(2):e53-e55. PubMed ID: 32835328
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis.
    Jabeen K; Farooqi J; Irfan M; Ali SA; Denning DW
    Lancet Infect Dis; 2021 Jun; 21(6):767. PubMed ID: 33662326
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspergillosis Complicating Severe Coronavirus Disease.
    Marr KA; Platt A; Tornheim JA; Zhang SX; Datta K; Cardozo C; Garcia-Vidal C
    Emerg Infect Dis; 2021 Jan; 27(1):18-25. PubMed ID: 33084566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for COVID-19-associated pulmonary aspergillosis.
    Brown LK; Ellis J; Gorton R; De S; Stone N
    Lancet Microbe; 2020 Aug; 1(4):e152. PubMed ID: 33521717
    [No Abstract]   [Full Text] [Related]  

  • 19. The Challenge of Managing COVID-19 Associated Pulmonary Aspergillosis.
    Brüggemann RJ; van de Veerdonk FL; Verweij PE
    Clin Infect Dis; 2021 Dec; 73(11):e3615-e3616. PubMed ID: 32810202
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
    Dellière S; Dudoignon E; Voicu S; Collet M; Fodil S; Plaud B; Chousterman B; Bretagne S; Azoulay E; Mebazaa A; Dépret F; Mégarbane B; Alanio A
    J Clin Microbiol; 2022 Mar; 60(3):e0216921. PubMed ID: 34985983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.